|
Market Closed -
Borsa Italiana
11:45:00 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 1.085 EUR | -0.46% |
|
-1.81% | -26.19% |
| 08-31 | Milan in the pink at the open, oil stocks lead the MIB | AN |
| 08-31 | Futures weak; Brent higher after US-Iran attacks | AN |
Company Valuation: Laboratorio Farmaceutico Erfo S.p.A.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Market Cap 1 | 18.27 | 11.79 | 10.8 | 12.53 |
| Change | - | -35.47% | -8.4% | 16.03% |
| Enterprise Value (EV) 1 | 17.38 | 11.41 | 10.81 | 12.83 |
| Change | - | -34.34% | -5.31% | 18.7% |
| P/E | 25.5x | 19.1x | 30.8x | 17x |
| PBR | 2.33x | 1.43x | 1.44x | 1.57x |
| PEG | -0.3x | -1.4x | -0.8x | 0x |
| Capitalization / Revenue | 3.87x | 1.99x | 1.79x | 1.29x |
| EV / Revenue | 3.68x | 1.92x | 1.79x | 1.32x |
| EV / EBITDA | 11.8x | 8.02x | 10.1x | 7x |
| EV / EBIT | 17.6x | 13.6x | 20.6x | 12x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | 0.06 | - | - |
| Rate of return | - | 4.58% | - | - |
| EPS 2 | 0.0796 | 0.0686 | 0.0411 | 0.0865 |
| Distribution rate | - | 87.4% | - | - |
| Net sales 1 | 4.719 | 5.932 | 6.032 | 9.732 |
| EBITDA 1 | 1.474 | 1.423 | 1.065 | 1.832 |
| EBIT 1 | 0.987 | 0.8367 | 0.5239 | 1.066 |
| Net income 1 | 0.7161 | 0.5903 | 0.3528 | 0.737 |
| Net Debt 1 | -0.8895 | -0.3784 | 0.005767 | 0.2954 |
| Reference price 2 | 2.030 | 1.310 | 1.265 | 1.470 |
| Nbr of stocks (in thousands) | 9,000 | 9,000 | 8,537 | 8,524 |
| Announcement Date | 4/12/23 | 5/8/24 | 4/14/25 | 4/12/26 |
1EUR in Million2EUR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 10.63M | ||
| 33.27x | 12.06x | 24.51x | 0.59% | 1,043B | ||
| 29.94x | 6.66x | 18.64x | 2% | 649B | ||
| 33.54x | 7.85x | 16.21x | 2.59% | 469B | ||
| 19.72x | 4.82x | 11.95x | 2.75% | 355B | ||
| 20.01x | 5.21x | 12.94x | 3.07% | 270B | ||
| 21.55x | 4.46x | 12.7x | 1.98% | 262B | ||
| 26.04x | 6.76x | 12.04x | 2.46% | 222B | ||
| -46.18x | 6.71x | 26.22x | 2.16% | 189B | ||
| 11.59x | 4.21x | 8.76x | 4.34% | 175B | ||
| Average | 16.61x | 6.53x | 16.00x | 2.44% | 363.3B | |
| Weighted average by Cap. | 23.93x | 7.81x | 18.02x | 1.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ERFO Stock
- Valuation Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions
















